Repositorio Dspace

Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs

Mostrar el registro sencillo del ítem

dc.contributor.author Lázaro-Cebas, Andrea
dc.contributor.author Caro-Teller, José-Manuel
dc.contributor.author García-Muñoz, Carmen
dc.contributor.author González-Gómez, Carlos
dc.contributor.author Ferrari-Piquero, José-Miguel
dc.contributor.author Lumbreras-Bermejo, Carlos
dc.contributor.author Romero-Garrido, José-Antonio
dc.contributor.author Benedi-González, Juana
dc.date.accessioned 2025-11-20T07:16:17Z
dc.date.available 2025-11-20T07:16:17Z
dc.date.issued 2022-02
dc.identifier.citation Lázaro Cebas A, Caro Teller JM, García Muñoz C, González Gómez C, Ferrari Piquero JM, Lumbreras Bermejo C, et al. Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs. BMC Health Serv Res. diciembre de 2022;22(1):167.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21526
dc.description.abstract BACKGROUND: Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its influence on readmissions and costs. METHODS: A single-centre study with an intervention group and a retrospective control group was conducted. The intervention was carried out in all polymedicated patients ? 65 years who were admitted to internal medicine and signed the informed consent between June 2017 and February 2018. Patients discharged to nursing homes or long-term hospitals were excluded. The control group were all the patients who were admitted during the same months of 2014 who met the same inclusion criteria. The patients were classified according to the HOSPITAL score as having a low, intermediate, or high risk of potentially avoidable readmission. Outcome measures were 30-day readmission and cost data. To analyse the effect of the intervention on readmission, a logistic regression was performed. RESULTS: The study included 589 patients (286 intervention group; 303 control group). The readmission rate decreased from 20.13% to 16.43% in the intervention group [OR = 0.760 95% CI (0.495-1.166); p = 0.209)]. The incremental cost for the intervention to prevent one readmission was ?3,091.19, and the net cost saving was ?1,301.26. In the intermediate- and high-risk groups, readmissions were reduced 10.91% and 10.00%, and the net cost savings were ?3,3143.15 and ?3,248.71, respectively. CONCLUSIONS: The pharmacist intervention achieved savings in the number of readmissions, and the net cost savings were greater in patients with intermediate and high risks of potentially avoidable readmission according to the HOSPITAL score.
dc.language.iso eng
dc.publisher BMC
dc.rights http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights.uri Atribución-NoComercial-SinDerivadas 3.0 España *
dc.subject.mesh Aged
dc.subject.mesh Humans
dc.subject.mesh Internal Medicine
dc.subject.mesh Patient Discharge
dc.subject.mesh Patient Readmission
dc.subject.mesh Pharmacists
dc.subject.mesh Retrospective Studies
dc.title Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35139838
dc.relation.publisherversion https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-022-07582-6
dc.identifier.doi 10.1186/s12913-022-07582-6
dc.journal.title Bmc Health Services Research
dc.identifier.essn 1472-6963


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta